ID

15610

Descripción

Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS); ODM derived from: https://clinicaltrials.gov/show/NCT00038805

Link

https://clinicaltrials.gov/show/NCT00038805

Palabras clave

Versiones (1)
  1. 4/6/16 4/6/16 -
Subido en

4 de junio de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Leukemia NCT00038805

Inglés

Eligibility Leukemia NCT00038805

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00038805
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients 12-75 years of age
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
patients are eligible if deemed ineligible for conventional high dose chemotherapy programs because of concurrent medical conditions. patients with refractory aml are eligible provided ejection fraction >= 35%; fev1, fvc, or dlco >= 40%; gpt < 3 x normal, direct bilirubin < 2.
Descripción

high dose chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1328050
UMLS CUI [1,2]
C1548635
patients must have recovered from previous grade iii-iv toxicity due to prior antineoplastic therapy (except alopecia).
Descripción

grade iii-iv toxicity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013221
patients with aml with induction failure, relapse or 2nd remission
Descripción

aml with induction failure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023467
patients with mds with ipi int-2 or high-risk disease or cmml.
Descripción

mds with ipi int-2 or high-risk disease or cmml

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3463824
UMLS CUI [2]
C0023480
patients with cml in accelerated phase or blast crisis
Descripción

cml in accelerated phase or blast crisis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023473
UMLS CUI [1,2]
C0457345
UMLS CUI [2,1]
C0023473
UMLS CUI [2,2]
C0005699
patients with all with induction failure, relapse or 2nd remission
Descripción

all with induction failure, relapse or 2nd remission

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023449
patients receiving prior bmt are eligible. if myeloablative chemoradiotherapy was used in the prior transplant patients must be >90 days from transplant. if non-myeloablative therapy was used patients must be >30 days post-transplant.
Descripción

bmt

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005961
leukemia cells must express cell surface cd33 evaluated by flow cytometry in > 20% of leukemia cells.
Descripción

express cell surface cd33

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3491277
patients must have an hla identical related donor capable of donating g-csf stimulated peripheral blood stem cells using apheresis techniques. if patient has a contraindication to pbsc collection bone marrow can be used.
Descripción

hla identical related donor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019633
patients must have a zubrod ps <2, cr <2.0, direct bilirubin <2, and transaminases sgpt <3x normal
Descripción

zubrod ps

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3714786
UMLS CUI [2]
C0201916
UMLS CUI [3]
C0201836
patients must have an estimated life expectancy > 3 months
Descripción

life expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
patient and donor must sign informed consent
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
no uncontrolled active infection
Descripción

uncontrolled active infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
no hiv disease
Descripción

hiv disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019682
no pregnancy and no nursing
Descripción

pregnancy and nursing

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
no active, uncontrolled cns leukemia
Descripción

cns leukemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1332884
Volver a la parte superior de la página

Similar models

Eligibility Leukemia NCT00038805

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00038805
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patients 12-75 years of age
boolean
C0001779 (UMLS CUI [1])
high dose chemotherapy
Item
patients are eligible if deemed ineligible for conventional high dose chemotherapy programs because of concurrent medical conditions. patients with refractory aml are eligible provided ejection fraction >= 35%; fev1, fvc, or dlco >= 40%; gpt < 3 x normal, direct bilirubin < 2.
boolean
C1328050 (UMLS CUI [1,1])
C1548635 (UMLS CUI [1,2])
grade iii-iv toxicity
Item
patients must have recovered from previous grade iii-iv toxicity due to prior antineoplastic therapy (except alopecia).
boolean
C0013221 (UMLS CUI [1])
aml with induction failure
Item
patients with aml with induction failure, relapse or 2nd remission
boolean
C0023467 (UMLS CUI [1])
mds with ipi int-2 or high-risk disease or cmml
Item
patients with mds with ipi int-2 or high-risk disease or cmml.
boolean
C3463824 (UMLS CUI [1])
C0023480 (UMLS CUI [2])
cml in accelerated phase or blast crisis
Item
patients with cml in accelerated phase or blast crisis
boolean
C0023473 (UMLS CUI [1,1])
C0457345 (UMLS CUI [1,2])
C0023473 (UMLS CUI [2,1])
C0005699 (UMLS CUI [2,2])
all with induction failure, relapse or 2nd remission
Item
patients with all with induction failure, relapse or 2nd remission
boolean
C0023449 (UMLS CUI [1])
bmt
Item
patients receiving prior bmt are eligible. if myeloablative chemoradiotherapy was used in the prior transplant patients must be >90 days from transplant. if non-myeloablative therapy was used patients must be >30 days post-transplant.
boolean
C0005961 (UMLS CUI [1])
express cell surface cd33
Item
leukemia cells must express cell surface cd33 evaluated by flow cytometry in > 20% of leukemia cells.
boolean
C3491277 (UMLS CUI [1])
hla identical related donor
Item
patients must have an hla identical related donor capable of donating g-csf stimulated peripheral blood stem cells using apheresis techniques. if patient has a contraindication to pbsc collection bone marrow can be used.
boolean
C0019633 (UMLS CUI [1])
zubrod ps
Item
patients must have a zubrod ps <2, cr <2.0, direct bilirubin <2, and transaminases sgpt <3x normal
boolean
C3714786 (UMLS CUI [1])
C0201916 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
life expectancy
Item
patients must have an estimated life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
informed consent
Item
patient and donor must sign informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
uncontrolled active infection
Item
no uncontrolled active infection
boolean
C0009450 (UMLS CUI [1])
hiv disease
Item
no hiv disease
boolean
C0019682 (UMLS CUI [1])
pregnancy and nursing
Item
no pregnancy and no nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
cns leukemia
Item
no active, uncontrolled cns leukemia
boolean
C1332884 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial